394 related articles for article (PubMed ID: 30373547)
1. Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study.
DiBernardo A; Lin X; Zhang Q; Xiang J; Lu L; Jamieson C; Benson C; Lee K; Bodén R; Brandt L; Brenner P; Reutfors J; Li G
BMC Psychiatry; 2018 Oct; 18(1):352. PubMed ID: 30373547
[TBL] [Abstract][Full Text] [Related]
2. The humanistic and economic burden of treatment-resistant depression in Europe: a cross-sectional study.
Jaffe DH; Rive B; Denee TR
BMC Psychiatry; 2019 Aug; 19(1):247. PubMed ID: 31391065
[TBL] [Abstract][Full Text] [Related]
3. Impact of fatigue on outcome of selective serotonin reuptake inhibitor treatment: secondary analysis of STAR*D.
Ferguson M; Dennehy EB; Marangell LB; Martinez J; Wisniewski SR
Curr Med Res Opin; 2014 Oct; 30(10):2109-18. PubMed ID: 24949937
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
[TBL] [Abstract][Full Text] [Related]
5. A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting.
Ishak WW; Balayan K; Bresee C; Greenberg JM; Fakhry H; Christensen S; Rapaport MH
Qual Life Res; 2013 Apr; 22(3):585-96. PubMed ID: 22544416
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life burden associated with treatment-resistant depression in UK patients: Quantitative results from a mixed-methods non-interventional study.
Rathod S; Denee T; Eva J; Kerr C; Jacobsen N; Desai M; Baldock L; Young AH
J Affect Disord; 2022 Mar; 300():551-562. PubMed ID: 34965398
[TBL] [Abstract][Full Text] [Related]
7. Correlation between depression/anxiety symptom severity and quality of life in patients with major depressive disorder or bipolar disorder.
Gao K; Su M; Sweet J; Calabrese JR
J Affect Disord; 2019 Feb; 244():9-15. PubMed ID: 30292023
[TBL] [Abstract][Full Text] [Related]
8. Toward a very brief quality of life enjoyment and Satisfaction Questionnaire.
Rush AJ; South CC; Jha MK; Grannemann BD; Trivedi MH
J Affect Disord; 2019 Jan; 242():87-95. PubMed ID: 30173063
[TBL] [Abstract][Full Text] [Related]
9. Importance of remission and residual somatic symptoms in health-related quality of life among outpatients with major depressive disorder: a cross-sectional study.
Woo JM; Jeon HJ; Noh E; Kim HJ; Lee SW; Lee KK; Kim SH; Hong JP
Health Qual Life Outcomes; 2014 Dec; 12():188. PubMed ID: 25519704
[TBL] [Abstract][Full Text] [Related]
10. Predicting clinical course in major depressive disorder: The association between DM-TRD score and symptom severity over time in 1115 outpatients.
van Dijk DA; van den Boogaard TM; Deen ML; Spijker J; Ruhé HG; Peeters FPML
Depress Anxiety; 2019 Apr; 36(4):345-352. PubMed ID: 30474901
[TBL] [Abstract][Full Text] [Related]
11. Ketamine vs Electroconvulsive Therapy for Treatment-Resistant Depression: A Secondary Analysis of a Randomized Clinical Trial.
Jha MK; Wilkinson ST; Krishnan K; Collins KA; Sanacora G; Murrough J; Goes F; Altinay M; Aloysi A; Asghar-Ali A; Barnett B; Chang L; Costi S; Malone D; Nikayin S; Nissen SE; Ostroff R; Reti I; Wolski K; Wang D; Hu B; Mathew SJ; Anand A
JAMA Netw Open; 2024 Jun; 7(6):e2417786. PubMed ID: 38916891
[TBL] [Abstract][Full Text] [Related]
12. Incorporating multidimensional patient-reported outcomes of symptom severity, functioning, and quality of life in the Individual Burden of Illness Index for Depression to measure treatment impact and recovery in MDD.
Cohen RM; Greenberg JM; IsHak WW
JAMA Psychiatry; 2013 Mar; 70(3):343-50. PubMed ID: 23303512
[TBL] [Abstract][Full Text] [Related]
13. Chronic Vagus Nerve Stimulation Significantly Improves Quality of Life in Treatment-Resistant Major Depression.
Conway CR; Kumar A; Xiong W; Bunker M; Aaronson ST; Rush AJ
J Clin Psychiatry; 2018 Aug; 79(5):. PubMed ID: 30152645
[TBL] [Abstract][Full Text] [Related]
14. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
[TBL] [Abstract][Full Text] [Related]
15. A randomised controlled trial of Intensive Short-Term Dynamic Psychotherapy for treatment resistant depression: the Halifax Depression Study.
Town JM; Abbass A; Stride C; Bernier D
J Affect Disord; 2017 May; 214():15-25. PubMed ID: 28266318
[TBL] [Abstract][Full Text] [Related]
16. Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.
Demyttenaere K; Andersen HF; Reines EH
Int Clin Psychopharmacol; 2008 Sep; 23(5):276-86. PubMed ID: 18703937
[TBL] [Abstract][Full Text] [Related]
17. Improvements in quality of life with desvenlafaxine 50mg/d vs placebo in employed adults with major depressive disorder.
Endicott J; Lam RW; Hsu MA; Fayyad R; Boucher M; Guico-Pabia CJ
J Affect Disord; 2014 Sep; 166():307-14. PubMed ID: 25012446
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life in depression: a STAR*D report.
Daly EJ; Trivedi MH; Wisniewski SR; Nierenberg AA; Gaynes BN; Warden D; Morris DW; Luther JF; Farabaugh A; Cook I; Rush AJ
Ann Clin Psychiatry; 2010 Feb; 22(1):43-55. PubMed ID: 20196982
[TBL] [Abstract][Full Text] [Related]
19. [Association between health related quality of life and severity of depression in patients with major depressive disorder].
Cao Y; Li W; Shen J; Zhang Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 36(2):143-8. PubMed ID: 21368424
[TBL] [Abstract][Full Text] [Related]
20. Mindfulness-based cognitive therapy (MBCT) versus the health-enhancement program (HEP) for adults with treatment-resistant depression: a randomized control trial study protocol.
Eisendrath SJ; Gillung EP; Delucchi KL; Chartier M; Mathalon DH; Sullivan JC; Segal ZV; Feldman MD
BMC Complement Altern Med; 2014 Mar; 14():95. PubMed ID: 24612825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
